原发性肝癌合并肺转移的双重介入治疗的研究

The study of dual interventional treatment for primary hepatic carcinoma with pulmonary metastasis

目的探讨临床双重介入治疗原发性肝癌合并肺转移的临床效果。方法对40例晚期原发性肝癌合并肺转移的患者,采用经股动脉穿刺插管选择性经肝动脉分支和支气管动脉进行化疗栓塞术。结果原发性肝癌有效率为45%(18/40),肺转移灶有效率为40%(16/40)。原发性肝癌合并肺转移有效率为37.5%(15/40),半年和1年生存率分别为80%和37.5%。结论临床经肝动脉分支和支气管动脉双重联合介入治疗原发性肝癌合并肺转移是一种安全、有效的姑息性治疗方法。

Objective To study the clinical effect of dual interventional treatment for primary hepatic carcinoma with pulmonary metastasis. Methods Percutaneous selective hepatic arterial and bronchial arterial chemotherapy and/or embolization together was performed in 40 patients with primary hepatic carcinoma with pulmonary metastasis. Results The effective rates of hepatic tumor with pulmonary metastasis were 18/40, 16/40 and 15/40 respectively. The survival rate in 0.5 and 1 year were 80% and 37. 5%. Conclusion Dual infusion interventional treatment for primary hepatic carcinoma with pulmonary metastasis by both hepatic arterial chemoembolization and bronchial arterial chemotherapy and/or embolization is a safe and effective palliative treatment.